Group 1: Reusable Rocket Developments - China’s commercial aerospace company, Blue Arrow Aerospace, announced that the reusable rocket Zhuque-3 will conduct recovery tests in Q2 2026, optimizing the landing process for potential reuse [1] - The Zhuque-3 rocket's first stage, if successfully recovered, will be used for subsequent launches, aiming for a reusable flight by Q4 2026 [1] Group 2: Launch Plans and Achievements - China Aerospace Science and Technology Corporation (CASC) revealed that the recoverable liquid rocket, Lijian-2, is set for its maiden flight in late March 2026, carrying the light cargo spacecraft [2] - CASC plans to conduct four launches within the year, with the solid rocket Lijian-1 expected to have at least eight launches, including two at sea [2] Group 3: Hong Kong's Aerospace Initiatives - Hong Kong's Financial Secretary, Paul Chan, stated that the government is reviewing listing regulations to attract more aerospace companies to the region [3] - The government aims to facilitate the integration of mainland aerospace industries with global markets, providing various professional services [3] Group 4: Autonomous Driving Projects - The "Aerospace Corridor" autonomous driving transport system is expected to be operational within the year, marking the first commercial operation of its kind in Hong Kong [4] Group 5: Technological Innovations in Fuel Cells - A research team from Northwestern Polytechnical University and Peking University has developed a novel strategy to address carbon deposition in solid oxide fuel cells, enhancing the conversion of natural gas to electricity [5] Group 6: Advancements in Medical Technology - Researchers from the University of Pennsylvania and Harvard have created an electronic implant system that monitors and influences the development of human pancreatic cells, providing a platform for future diabetes therapies [6] Group 7: Gene Editing in Medical Treatments - A team from the Air Force Medical University successfully performed the first gene-edited pig liver perfusion treatment for a patient with liver failure, demonstrating safety and efficacy [7] Group 8: Semiconductor Manufacturing Improvements - Samsung Electronics has achieved an 80% yield rate for its 1C DRAM, significantly up from 60-70% in Q4 2025, with expectations to reach 90% by May [8] - The yield for Samsung's HBM4 based on 1C DRAM has also improved, nearing 60% compared to 50% in Q4 2025 [8] Group 9: Policy Initiatives in Sichuan - The Sichuan provincial government has expanded its "computing power voucher" program and is exploring new policies to support digital innovation, including funding for digital application laboratories [9] Group 10: AI Model Developments by Alibaba - Alibaba has released three new medium-sized models in the Qwen 3.5 series, outperforming previous flagship models, with costs as low as 0.2 yuan per million tokens [10]

原标题：电子植入系统可监测胰岛细胞发育过程为构建功能成熟的人源胰岛提供关键技术平台 研究人员开发出一种电子植入系统，能通过电信号监测并影响人类胰岛细胞的成熟过程（示意图）。 图片来源：物理学家组织网/哈佛大学工程与应用科学学院 美国宾夕法尼亚大学佩雷尔曼医学院和哈佛大学工程与应用科学学院的科学家开发出一种电子植入系 统，能通过电信号监测并影响人类胰岛细胞发育成熟的过程。这一成果为构建真正功能成熟的人源胰岛 提供了关键技术平台，也为未来基于细胞的糖尿病疗法提供了新思路。相关论文发表于最新一期《科 学》杂志。 团队在实验室培养的正在生长的胰腺组织中嵌入一层超薄导电网状结构，使电子装置与生物组织紧密结 合。这一系统就能记录胰岛细胞产生的电信号，还能向细胞施加精确电刺激，从而影响其发育过程。 在1型糖尿病中，免疫系统会攻击胰岛细胞，使其失去分泌胰岛素的能力。对部分患者来说，替代受损 细胞通常需要胰腺或胰岛移植，但供体稀缺且术后需长期使用免疫抑制药物。因此，在实验室培养功能 完善的胰腺组织被视为一种潜在替代方案。 此次研究中，团队在发育中的三维胰腺类器官内部植入一张可拉伸的电子网。这种结构比头发丝还细， 被放置在细胞层 ...

研究团队表示，这一思路其实并不陌生，例如用于治疗神经系统疾病的深部脑刺激技术，本质上也是通 过电信号调节人体器官功能。 美国宾夕法尼亚大学佩雷尔曼医学院和哈佛大学工程与应用科学学院的科学家开发出一种电子植入系 统，能通过电信号监测并影响人类胰岛细胞发育成熟的过程。这一成果为构建真正功能成熟的人源胰岛 提供了关键技术平台，也为未来基于细胞的糖尿病疗法提供了新思路。相关论文发表于最新一期《科 学》杂志。 团队在实验室培养的正在生长的胰腺组织中嵌入一层超薄导电网状结构，使电子装置与生物组织紧密结 合。这一系统就能记录胰岛细胞产生的电信号，还能向细胞施加精确电刺激，从而影响其发育过程。 这种装置既可称为"仿生"，也可称为"赛博类器官"，即电子系统与活体组织共同组成一个可被调控的生 物系统。 这一过程不仅改变了单个细胞的电行为，也促进了细胞之间的协同工作，使其更接近天然胰岛的功能状 态。 研究团队认为，这项技术未来可能有两种应用方式：一种是先通过电刺激"训练"实验室培养的胰岛细 胞，再将其移植到患者体内；另一种则是在移植后保留电子网状结构，用于持续监测并适度刺激细胞， 以防其在压力或疾病影响下功能退化。 （文章来源：科 ...